Trans-cleaving hammerhead ribozymes (hhRzs), where stem-loops I and III are open-ended (I/III), have been widely used for the endonucleolytic cleavage of any specific RNA substrate. However, the application of hhRzs for use in gene therapy, especially for use in the targeted knockdown of HIV gene expression and replication, has been hampered by a low intracellular catalytic efficiency. As a result, therapeutic applications that exploit the RNA Interference (RNAi) pathway are presently more attractive than ribozymes. Recent studies have shown that the catalytic efficiency of naturally-derived cis-cleaving hhRzs is several orders of magnitude higher when compared to trans-cleaving counterparts. Moreover, changes made to stem-loops I and II, which are nonconserved sequence elements peripheral to the minimal essential catalytic core, greatly affect the catalytic turnover of cis-acting hhRzs. In this study, we designed two hhRzs variants with alterations intended to mimic stem-loop interactions found in the hhRz derived from satellite RNA of tobacco ringspot virus (sTRSV) to generate trans-cleaving hhRzs targeted to an accessible region within the HIV-1 rev sequence. Kinetic analyses were performed under multiple turnover conditions using an 18-mer synthetic RNA substrate at submillimolar levels. Under standard conditions (pH 7, 37°C, 10 mM MgCl2) the rate of cleavage (kobs) for hhRz variant sII-RV2 was significantly better than that of the conventional I/III hhRz, sII-RV3, with kobs of 0.24 min-1 and 0.094 min-1 respectively. HhRz variant sII-RV1, which differed from sII-RV2 only in the position of the peripheral stem, but with an identical loop, showed almost no substrate cleavage. These results may reflect the presence of a tertiary interaction between stem-loops I and 2 that facilitate cleavage. Alternatively, the addition of a mimicked stem-loop I possibly stabilizes active hhRz conformers.
Read full abstract